Orca Bio, a late-stage biotechnology company focused on transforming patient care through high-precision cell therapy, presented clinical findings today at the 66th American Society of Hematology (ASH) Annual Meeting. The…
Alithea Genomics, a leader in RNA sequencing and transcriptomics, has introduced its MERCURIUS™ Full-Length DRUG-seq library preparation technology. This groundbreaking innovation combines massive sample multiplexing, an extraction-free workflow, and full…
MEDIPAL HOLDINGS CORPORATION (TSE 7459, MEDIPAL) and JCR Pharmaceuticals Co., Ltd. (TSE 4552, JCR) announced today the initiation of the Phase I/II clinical trial for JR-446 in Japan, with the…
Cencora, a global healthcare leader, has introduced Accelerate Pharmacy Solutions, a comprehensive suite of services aimed at helping hospital and health system customers streamline operations and improve financial performance. This…
Parse Biosciences, a leader in accessible and scalable single-cell sequencing solutions, has announced the creation of the world’s largest single-cell dataset to date, comprising 100 million cells. This milestone was…
LivaNova PLC (Nasdaq: LIVN), a leading medical technology company, announced its participation in the American Epilepsy Society (AES) 2024 Annual Meeting, held December 6-10 in Los Angeles. The company will…
Foundation Medicine, Inc. has announced the awarding of two grants to organizations focused on reducing disparities in biomarker testing for breast and prostate cancer. These grants follow an open call…
Novocure (NASDAQ: NVCR) announced that its pivotal Phase 3 PANOVA-3 trial successfully met its primary endpoint, showing a statistically significant improvement in median overall survival (mOS) compared to the control…
ILiAD Biotechnologies, a clinical-stage biotech company focused on preventing and treating diseases caused by Bordetella pertussis and other respiratory pathogens, announced that the U.K. Medicines & Healthcare Products Regulatory Agency…
Reveal Genomics, a Barcelona-based biotechnology startup focused on revolutionizing precision oncology through biomarker innovation, has partnered with the European Institute of Oncology (IEO) to launch a groundbreaking impact study on…
Aventa™ Genomics, LLC, a clinical laboratory specializing in 3D genomics to enhance patient outcomes and a wholly-owned subsidiary of Arima Genomics, Inc., announced today that it has received a favorable…
Maverick Medical AI has announced the successful deployment of its real-time, AI-powered autonomous medical coding solution at all 399 RadNet, Inc. (NASDAQ: RDNT) locations. RadNet is a national leader in…